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Moscow Research Institute for Cybernetic Medicine (MRICM) 
 
ABSTRACT 
 
It is proposed to use the method  of principal 
components (MPC) as an instrument for date’s 
analysis of oral glucose tolerance test (OGTT), which 
plays very important role in diabetic diagnoses. As it 
was shown on the basis of sufficiently representative 
clinical material, using of the MPC for OGTT data 
processing is very perspective. This is established, 
that  basic information about the presence and level of 
hyperinsulinemia is contained in the first principal 
component FACTOR1 and FACTOR1 values for 
healthy patients and patients with signs of pathology 
are clearly separated. There is a significant correlation 
values FACTOR1 and standard indices CARO, 
HOMA-IR, HAFFNER. The dynamics of change in 
F1 values can clearly judge about the efficiency of 
therapeutic procedures. 
 
Index Terms - Oral glucose tolerance test, method  
of principal components, diabetic diagnoses 
1. INTRODUCTION 
One of the most important problems in the medicine 
nowadays is the problem of the so called insulin 
resistance syndrome. Term “insulin resistance 
syndrome” means sensitivity reduction insulin-
dependent tissues to the hormone insulin. This 
hormone produced by pancreas and such a sensitivity 
reduction lead to the chronic hyperinsulinemia. 
Insulin resistance syndrome and hyperinsulinemia are 
the two main factors for the progress of diabetes 
mellitus and its complications, as well as the whole 
number оf pathological changes of metabolism and 
metabolic control united by the term “metabolic 
syndrome”.  
Investigations of the insulin resistance syndrome 
and of the associated pathological states may lead to 
development of the effective methods of diabetes 
mellitus prevention as well as the whole range of 
symptoms of the metabolic syndrome. 
Many methods for estimation of the insulin 
resistance exist. The most popular amongst them is 
oral glucose tolerance test (OGTT) [1]. This test is 
realized by the taking fasting of dry 75 g glucose 
dissolved in 250 ml of water, and measuring 
concentrations of immunoreactive insulin (IRI), and 
in enlarged version also glucose and C-peptide in 
blood plasma at the initial (zero) time and 30, 60, 120 
minutes after taking. Standard processing of test 
results is usually limited to fixing the initial and end 
levels of IRI and there confrontation [2], estimation of 
various indexes (CARO, HOMA-IR [3], “area under 
insulin curve”, HAFFNER, etc.).  The last indices are 
considered as the most informative ones and calculate 
as the sum of IRI concentrations in blood plasma at 
the initial (zero) time and 30, 60, 120 minutes after, or 
(for HAFFNER index [1]) as the same sum with 
weights 0,25, 0,5, 0,75 and 0,5 respectively. 
In practice we can see that findings from OGTT 
in the every individual case reflect good enough type 
and level of malfunction in insulin secretion and 
hyperinsulinemia. However, it is clear that such data 
processing does not allow to extract all useful 
information especially when IRI, glucose and C-
peptide are measured simultaneously.  In this case it is 
desirable to get integral representation about level of 
variability for each factor, that possibly reveals 
liaisons with clinical signs of insulin resistance. In 
one’s turn it gives opportunity for a new look to the 
estimation and objectification of the findings from the 
insulin resistance diagnostics and to an effectiveness 
of its correction methods. Further it is proposed to use 
the method of principal components (MPC) [4] as an 
instrument for data analysis of oral glucose tolerance 
test (OGTT). 
2. INVESTIGATION OF MPC AVAILABILITY 
FOR DATA ANALYSIS OF OGTT 
As well-known MPC serves for optimal 
dimensionality reduction of multidimensional initial 
data by means of the transformation to a new 
variables (principal components or factors) that are 
uncorrelated normalized linear combinations of the 
initial variables. MPC is mathematically defined as an 
orthogonal linear transformation that transforms the 
data to a new coordinate system such that the greatest 
variance by any projection of the data comes to lie on 
the first coordinate (called the first principal 
component), the second greatest variance on the 
second coordinate, and so on. It is assumed that only a 
few number of principal components (usually first 
two or three ones) can explain the largest part of 
common variance. The values in the remaining 
dimensions, therefore, tend to be highly correlated 
and may be dropped with minimal loss of 
information.  
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Investigation of MPC applicability for data 
analysis of OGTT included two steps. 
Step 1. The aim of this step was to reveal a principal 
possibility and usefulness of MPC for data processing 
of OGTT. Thereto it was important to answer a 
fundamentally question: is it possible with help of 
MPC to reliably classify data on healthy or sick 
patients, using  all OGTT factors (IRI, glucose and C-
peptide).  
Clinical material was obtained at the Clinic of the 
Moscow Institute of Cybernetic Medicine. Sample of 
32 patients with the signs of insulin resistance 
syndrome was considered (group 1). Control group 
(group 2) included 10 persons.  
Results of data processing of  OGTT are shown on 
the plane of two first principal components in Figure 
1, where circles represent patients from group 1 and 
triangles represent control group. 
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Figure 1: results of data processing (variant 1) 
 
It is clear, although points from distinct groups are 
generally separated, nevertheless it is quite difficult to 
draw a boundary line amongst them. For example if 
one draws a boundary line shown in the Figure 1 only 
two points get wrong classification (instead of group 
1 they  get group 2). 
In spite of quite favorable result let’s improve it by 
modification of the initial variables. It is proposed to 
use as initial variables concentrations of IRI, glucose 
and C-peptide in blood plasma at the initial (zero) 
time and their differences between relevant values in 
the two time moments: D1 – is the difference between 
values in point 30 minutes and zero time; D2- is the 
difference between values in points 60 and 30 
minutes, D3 - is the difference between values in 
points 120 and 60 minutes and D4 – is the difference 
between values in points 120 and 0 minutes. One can 
see that amongst variables D1,…, D4 only 3 ones are 
independent (each of considering variables may be 
found from 3 other ones), so one of them may be 
excluded. 
The analysis shows, that the best separation of 
points is obtained if initial values and  differences D2, 
D3, D4 are used. Results of data processing for this  
case are shown in the Figure 2. 
Here we can see that all the points from the 
different groups are strictly and simply separated by 
means of the only one factor (FACTOR 1). Further 
we will consider exactly this case.  
 
Initial  volumes, D2, D3, D4
-2,5 -2,0 -1,5 -1,0 -0,5 0,0 0,5 1,0 1,5 2,0 2,5
FACTOR 1
-4
-3
-2
-1
0
1
2
3
F
A
C
T
O
R
 2
 
Figure 2: results of data processing (variant 2) 
 
Statistical properties of the derived two-factor 
model are represented in the Table 1. 
Table 1 
 
Components 
Paired correlation coefficients 
FACTOR 1 FACTOR 2 
Initial Insulin -0,810192 -0,054413 
Initial Glucose -0,303697 0,470927 
Initial C-peptide -0,828973 0,043168 
D2 Insulin -0,514240 0,591197 
D3 Insulin -0,5121118 -0,741789 
D4 Insulin -0,772964 -0,271312 
D2 Glucose -0,712550 0,407881 
D3 Glucose 0,116337 -0,849556 
D4 Glucose -0,722621 -0,391643 
D2 C-peptide -0,5691115 0,621869 
D3 C-peptide -0,637267 -0,558332 
D4 C-peptide -0,768277 0,060255 
Part of total 
scattering data 
41% 25% 
Total 66% 
 
Pair correlation coefficients represented in the 
Table 1. allow to estimate which of the initial 
variables have the biggest correlation with FACTOR 
1  and  FACTOR 2. Particularly it is clear  that more 
informative in the term of the correlation with the 
component FACTOR 1 are initial values of IRI, C-
peptide, all variables P4 and variable P2 for glucose 
(respective significant coefficients highlighted in bold 
italics in the Table 1).  Table 1 also represent such 
part of the common variance of the all experimental 
data, that may be explained by means of the two first 
components. Remaining 34% most probably relate to 
individual patients organism’s features or to IRI, C-
peptide and glucose concentration measurement 
errors. 
To find out correlation between derived factors and 
the standard indices CARO, HOMA, HAFFNER, one 
should draw a diagram representing experimental 
points in the respective coordinate system and then 
the linear models describing relationship between 
factors and indexes can be built (see Figure 3 and 4).  
Correlation between the component FACTOR 1 
and the standard indices clearly expressed, in the 
meantime there is no such an obvious correlation 
between standard indices and  FACTOR 2. 
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Figure 3: relationship between Factor 1 and standard indexes 
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Figure 4: relationship between Factor 2 and standard indexes 
 
 
Therefore the FACTOR 1 can be used as one more 
quantitative characteristic of the insulin resistance. 
Let’s call it FIR index further. As to the component 
FACTOR 2 its interpretation is not obviously clear 
yet and may be an object for the further research. 
Self-descriptiveness from the position of the 
distinction healthy and sick patients for the FIR index 
obviously higher than for the standard ones. This fact 
is reflected on the diagram (see Figure 5), where one 
can see that points from the two different groups 
(patients and the control group) does not overlap only 
for FIR index, meanwhile for the other indices there is 
a considerable intersection. It comes to be clear 
because of FIR index includes much more initial 
information than the other ones. 
In whole results derived on the Step 1 show that 
MPC can be successfully used for data analysis of 
oral glucose tolerance test. 
Step 2. The aim of this step is the further analysis of 
the effectiveness of the introduced method on the 
extended patients contingent as well as investigation 
of its potential to estimate therapeutic procedures 
effectiveness by observation over a points dynamics 
on the principal component’s plane. This analysis 
based on the results obtained from the previous step, 
namely previously found  linear relationships have 
been used. These relationships are associated the 
initial observed values with principal components 
(let’s call them F1_calc, F2_calc). They provide an 
opportunity to find the position of experimental points 
in the plane  (F1_calc, F2_calc). Moreover the 
component F1_calc was shifted on –0.9 in order to 
bring the point which separates the two groups 
(patients and the control group) on the zero level for 
visual clearness: FIR = (F1_calc – 0,9). 
Total number of the patients on this step was 52, 
including 32 patients from the Step 1. 
Results of data processing of OGTT for the total 
set of the patients on the plane (FIR; F2_calc) are 
shown on the Figure 6. Here rhombs represent new 
patients, circles represent old patients and triangles 
represent the control group.  
Although as was shown above level of insulin 
resistance defined only by the component FIR (or 
F1_calc), for the better visual clarity we use the plane 
(F1_calc; F2_calc); moreover such approach may be 
useful for understanding of the FACTOR 2 
interpretation.  
Obviously clear that points from the different 
groups are divided as before 
For therapeutic procedure effectiveness estimation 
on the same plane (F1_calc; F2_calc) pares of points 
representing the initial conditions of the patients and 
their conditions after the therapy were drawn. 
Examples of such representation are shown on the 
Figure7, where arrows mark movement of patients 
representing points during the therapy. In whole only 
one patient from the 48 have passed course of the 
treatment ones, did not show any positive results.   
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Figure 5: comparison of standard indexes and FIR index  
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Figure 6: results of data processing for the total set of the patients 
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Figure 7: estimation of  therapeutic procedures effectiveness 
 
Obtained results indicate that the used method 
allows to get visual estimation of the effectiveness 
of the applied treatment and visual estimation of the 
quality of the resulting effect. 
3. ADDITIONAL CONSIDERATIONS  
As well-known, veracity and adequacy of the 
results derived by means of any statistical methods 
entirely depend on sampling representativeness and 
on its volume. In this sense MPC is not an 
exception. Therefore expressions derived from the 
data processing (data obtained from 42 persons) 
described above should consider only as some 
intermediate result. So these expressions need to be 
corrected while number of the patient increases. At 
the same time the problem of the method’s 
robustness (in a sense of  whether the conclusions 
derived from smaller sampling will stay correct 
while the sampling grow) is a very important one.  
For the analysis of the result’s stability the sample, 
containing 110 measurement (where 96 obtained 
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from 48 patients have passed course of the 
treatment, 4 measurement obtained from 4 patients 
have refused the treatment and 10 – from the 
control group) was used. With this sample the new 
and more accurate linear relationships were 
obtained to calculate location of experimental 
points in the plane (FIR; FACTOR 2). As an 
example of their using the scattering graph for the 
points from the first sample (analog of Figure 2) is 
presented on Figure 8).  
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Figure 8: results of data processing (new variant) 
 
Comparison of  the above-mentioned diagrams 
shows that though positions of the points have been 
slightly changed their general type of the 
conclusions about distinction of the points from the 
different groups (patients and the control groups) 
practically without any changes. It indicates that in 
the mentioned sense the method is stable (robust) 
and may be practically used for analysis of insulin 
resistance. Moreover for the further analysis  and 
practical application more accurate formulas for  
calculating FIR and FACTOR 2,  derived for 110 
measurements, should be used. These formulas 
have the form: 
 
FIR = 0,922 - 0,008*Gl(0) + 0,081*Gl(30) –  
- 0,083*Gl(60) - 0,075*Gl(120) - 0,082*Cp(0) + 
+0,043*Cp(30) - 0,003*Cp(60) - 0,095*Cp(120) 
- 0,022*IRI(0) + 0,002*IRI(30) - 0,006*IRI(120) 
 
FACTOR 2 = - 0,989 +  0,151*Gl(0) –  
-0,084*Gl(30) + 0,257*Gl(60) - 0,233*Gl(120) + 
+0,010*Cp(0) + 0,091*Cp(30) - 0,142*Cp(60) + 
+0,042*Cp(120) +0,002*IRI(0) +0,008*IRI(30) - 
- 0,015*IRI(60) + 0,008*IRI(120). 
 
Here Gl(t), Cp(t), IRI(t) – measured values of the 
glucose (mmol/l), C-peptide (nmol/l) and IRI 
(mkME/ml) respectively, where t equals to 0, 30, 
60, 120.  
These expressions should be considered as the 
second iteration for determination of the required 
formulas. They may be corrected again while the 
sampling grows. As one can expect level of 
variability of the coefficients in the considering 
expressions will gradually reduce and their values 
will tend to some theoretical limit. 
 
4. RESUME 
1) Obtained results indicate availability of 
MPC for data analysis of oral glucose tolerance test 
(OGTT). 
2) Research of the potential of the described 
method should be proceeded at least in two 
directions: 
- analysis of the boundary line between two 
sets of points from the two groups: patients 
group and the control group; 
- analysis of the connection between points 
clustering on the principal components plane 
and the standard characteristics of the insulin 
resistance and metabolic syndrome.  
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